Abstract
BackgroundAnti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder that is increasingly recognized as an important cause of autoimmune encephalitis. It is especially important to consider, because its symptoms can be severe, yet potentially treatable. The best outcome depends on prompt immunotherapy and complete tumor removal if present. Its diverse presentations often cause delay in its diagnosis and treatment.Case presentationWe describe here a 15-year-old male who developed anti-NMDA encephalitis that was a particular challenge to diagnose. The course of his disease was also complicated with sinus thrombosis. He received immunotherapy in the form of IV steroids, plasma exchange, IVIG and finally rituximab together with anticoagulation resulting in complete improvement in his condition.ConclusionsAnti-NMDAR disease should be suspected in any young individual who develops encephalopathy associated with seizures, psychiatric symptoms and/or movement disorders. Identification of NMDAR antibodies confirms the diagnosis and should prompt early intervention with immunotherapy and neoplastic workup.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.